Table of Contents
ISRN Oncology
Volume 2012, Article ID 167545, 6 pages
http://dx.doi.org/10.5402/2012/167545
Research Article

The Role of Somatostatin Receptor Scintigraphy on the Diagnosis of Desmoid Tumors

1Department of Orthopedic Surgery, Medical University of Graz, Auenbruggerplatz 5, 8036 Graz, Austria
2Division of Nuclear Medicine Radiology, Department of Radiology, Medical University of Graz, Auenbruggerplatz 9, 8036 Graz, Austria
3Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036 Graz, Austria

Received 6 March 2012; Accepted 12 April 2012

Academic Editors: N. A. Franken, G. Gatti, and J. Klijanienko

Copyright © 2012 Joerg Friesenbichler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Goldblum and J. A. Fletcher, “Desmoid-type fibromatoses,” in World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, C. D. M. Fletcher, K. K. Unni, and F. Mertens, Eds., pp. 83–84, IARC Press, Lyon, France, 2002. View at Google Scholar
  2. J. R. Goldblum and J. A. Fletcher, “Superficial fibromatoses,” in World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, C. D. M. Fletcher, K. K. Unni, and F. Mertens, Eds., pp. 81–82, IARC Press, Lyon, France, 2002. View at Google Scholar
  3. S. W. Weiss and J. R. Goldblum, “Fibromatoses,” in Enzinger and Weiss's Soft Tissue Tumors, S. W. Weiss and J. R. Goldblum, Eds., pp. 227–255, Mosby Elsevier, St. Louis, Mo, USA, 5th edition, 2008. View at Google Scholar
  4. A. Leithner, M. Gapp, K. Leithner et al., “Margins in extra-abdominal desmoid tumors: a comparative analysis,” Journal of Surgical Oncology, vol. 86, no. 3, pp. 152–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Castellazzi, D. Vanel, A. Le Cesne et al., “Can the MRI signal of aggressive fibromatosis be used to predict its behavior?” European Journal of Radiology, vol. 69, no. 2, pp. 222–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. de Schepper and J. E. Vandevenne, “Tumors of connective tissue,” in Imaging of Soft Tissue Tumors, A. M. de Schepper, Ed., pp. 167–202, Springer, Berlin, Germany, 3rd edition, 2006. View at Google Scholar
  7. G. Guglielmi, A. Cifaratti, G. Scalzo, and N. Magarelli, “Imaging of superficial and deep fibromatosis,” Radiologia Medica, vol. 114, no. 8, pp. 1292–1307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. S. Hosalkar, E. J. Fox, T. Delaney, J. T. Torbert, C. M. Ogilvie, and R. D. Lackman, “Desmoid tumors and current status of management,” Orthopedic Clinics of North America, vol. 37, no. 1, pp. 53–63, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. C. Lee, J. M. Thomas, S. Phillips, C. Fisher, and E. Moskovic, “Aggressive fibromatosis: MRI features with pathologic correlation,” American Journal of Roentgenology, vol. 186, no. 1, pp. 247–254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. Murphey, C. M. Ruble, S. M. Tyszko, A. M. Zbojniewicz, B. K. Potter, and M. Miettinen, “From the archives of the AFIP: musculoskeletal fibromatoses: radiologic-pathologic correlation,” Radiographics, vol. 29, no. 7, pp. 2143–2176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. J. Papagelopoulos, A. F. Mavrogenis, E. A. Mitsiokapa, K. T. Papaparaskeva, E. C. Galanis, and P. N. Soucacos, “Current trends in the management of extra-abdominal desmoid tumours,” World Journal of Surgical Oncology, vol. 4, article 21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. A. Breeman, M. de Jong, D. J. Kwekkeboom et al., “Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives,” European Journal of Nuclear Medicine, vol. 28, no. 9, pp. 1421–1429, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. de Jong, W. A. P. Breeman, D. J. Kwekkeboom, R. Valkema, and E. P. Krenning, “Tumor imaging and therapy using radiolabeled somatostatin analogues,” Accounts of Chemical Research, vol. 42, no. 7, pp. 873–880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Florio, L. Montella, A. Corsaro et al., “In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors,” Anticancer Research, vol. 23, no. 3B, pp. 2465–2471, 2003. View at Google Scholar · View at Scopus
  15. W. W. de Herder, D. J. Kwekkeboom, R. A. Feelders et al., “Somatostatin receptor imaging for neuroendocrine tumors,” Pituitary, vol. 9, no. 3, pp. 243–248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Bombardieri, V. Ambrosini, C. Aktolun et al., “I111n-pentetreotide scintigraphy: procedure guidelines for tumour imaging,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 7, pp. 1441–1448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. R. Buscombe and E. Bombardieri, “Imaging cancer using single photon techniques,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 2, pp. 121–131, 2005. View at Google Scholar · View at Scopus
  18. M. Gabriel, C. Decristoforo, E. Donnemiller et al., “An intrapatient comparison of T99mc-EDDA/HYNIC-TOC with I111n-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors,” Journal of Nuclear Medicine, vol. 44, no. 5, pp. 708–716, 2003. View at Google Scholar · View at Scopus
  19. B. E. Chrapko, A. Nocuń, R. Gołȩbiewska et al., “T99mc-EDDA/HYNIC-TOC somatostatin receptor scintigraphy in daily clinical practice,” Medical Science Monitor, vol. 16, no. 4, pp. 35–44, 2010. View at Google Scholar · View at Scopus
  20. C. Decristoforo, S. J. Mather, W. Cholewinski, E. Donnemiller, G. Riccabona, and R. Moncayo, “T99mc-EDDA/HYNIC-TOC: a new T99mc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with I111n-labelled octreotide derivatives,” European Journal of Nuclear Medicine, vol. 27, no. 9, pp. 1318–1325, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Kreuzberg, J. Koudelova, J. Ferda, V. Treska, V. Spidlen, and P. Mukensnabl, “Diagnostic problems of abdominal desmoid tumors in various locations,” European Journal of Radiology, vol. 62, no. 2, pp. 180–185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. T. de Pas, L. Bodei, G. Pelosi et al., “Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group,” British Journal of Cancer, vol. 88, no. 5, pp. 645–647, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Müssig, M. O. Öksüz, K. Dudziak et al., “Association of somatostatin receptor 2 immunohistochemical expression with [I111n]-DTPA octreotide scintigraphy and [G68a]-DOTATOC PET/CT in neuroendocrine tumors,” Hormone and Metabolic Research, vol. 42, no. 8, pp. 599–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Fischer, C. Doll, S. Jacobs, A. Kolodziej, R. Stumm, and S. Schulz, “Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, pp. 4519–4524, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Reubi, A. Kappeler, B. Waser, J. Laissue, R. W. Hipkin, and A. Schonbrunn, “Immunohistochemical localization of somatostatin receptors sst2A in human tumors,” American Journal of Pathology, vol. 153, no. 1, pp. 233–245, 1998. View at Google Scholar · View at Scopus
  26. M. Körner, V. Eltschinger, B. Waser, A. Schonbrunn, and J. C. Reubi, “Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography,” The American Journal of Surgical Pathology, vol. 29, no. 12, pp. 1642–1651, 2005. View at Google Scholar · View at Scopus
  27. M. Volante, M. P. Brizzi, A. Faggiano et al., “Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy,” Modern Pathology, vol. 20, no. 11, pp. 1172–1182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Asnacios, F. Courbon, P. Rochaix et al., “Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors,” Journal of Clinical Oncology, vol. 26, no. 6, pp. 963–970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Leithner, M. Gapp, R. Radl et al., “Immunohistochemical analysis of desmoid tumours,” Journal of Clinical Pathology, vol. 58, no. 11, pp. 1152–1156, 2005. View at Publisher · View at Google Scholar · View at Scopus